Related Experiment Video
Updated: May 30, 2025

Establishing a Device for Sleep Deprivation in Mice
Published on: September 22, 2023
Sleep deprivation accelerates Parkinson's disease via modulating gut microbiota associated microglial activation and
Wenzhong Zhu1, Yuan Hu1, Yongping Shi1
1Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, PR China.
Abstract:
The interplay between Parkinson's disease (PD) and sleep disturbances suggests that sleep problems constitute a risk factor for PD progression, but the underlying mechanisms remain unclear. Microglial activation and oxidative stress are considered to play an important role in the pathogenesis of aging and neurodegenerative diseases. We hypothesized that sleep deprivation (SD) could exacerbate PD progression via modulating microglial activation and oxidative stress. To test this hypothesis, we established a PD mouse model using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), then subjected the mice to SD. A battery of behavioral tests, including rotarod, pole, adhesive removal, and open field tests, were used to assess motor function. Our study showed that SD exacerbated motor deficits, loss of tyrosine hydroxylase (TH), microglial activation and oxidative stress damage in PD model mice. Fecal microbiota transplantation experiments revealed that SD mediated PD progression, microglial activation and oxidative stress via the gut microbiota. 16S rRNA sequencing analysis indicated that SD increased the abundances of bacteria such as Bacteroidaceae, while decreasing the abundances of bacteria including Lactobacillus. Non-targeted metabolomic analysis of gut microbiota-derived metabolites revealed that SD significantly increased the production of adenosine (ADO), a purine metabolite. Probiotic supplementation reversed the effects of SD on motor deficits, dopaminergic neuron loss, microglial activation and oxidative stress damage in PD mice; it also decreased SD-induced ADO production. Administration of Adenosine A2A receptor (A2AR) inhibitors, Istradefylline (Ist), attenuated the roles of SD and ADO in promoting microglial activation, oxidative stress and PD progression. Taken together, our findings indicate that SD accelerates PD progression via regulating microbiota associated microglial activation and oxidative stress, suggesting that efforts to improve sleep quality can be used to prevent and treat PD.
Insights
Sleep deprivation worsens Parkinson's disease (PD) motor deficits by increasing microglial activation and oxidative stress through gut microbiota changes. Improving sleep may help prevent and treat PD.
Area of Science:
- Neuroscience
- Microbiology
- Pharmacology
Background:
- Sleep disturbances are linked to Parkinson's disease (PD) progression, but mechanisms are unclear.
- Microglial activation and oxidative stress are implicated in neurodegeneration.
- Sleep deprivation (SD) may exacerbate PD via these pathways.
Purpose of the Study:
- To investigate if sleep deprivation exacerbates Parkinson's disease progression.
- To explore the role of microglial activation, oxidative stress, and gut microbiota in this process.
- To identify potential therapeutic targets for mitigating SD-induced PD progression.
Main Methods:
- Established a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model.
- Subjected mice to sleep deprivation (SD) and assessed motor function using behavioral tests.
- Analyzed microglial activation, oxidative stress, gut microbiota composition (16S rRNA), and metabolites.
- Utilized fecal microbiota transplantation, probiotic supplementation, and Adenosine A2A receptor (A2AR) inhibitors (Istradefylline).
Main Results:
- SD worsened motor deficits, dopaminergic neuron loss, microglial activation, and oxidative stress in PD mice.
- SD altered gut microbiota composition, increasing Bacteroidaceae and decreasing Lactobacillus.
- SD elevated adenosine (ADO) production by gut microbiota.
- Probiotics and A2AR inhibitors reversed SD-induced deficits and pathological changes.
Conclusions:
- Sleep deprivation accelerates Parkinson's disease progression through gut microbiota-mediated microglial activation and oxidative stress.
- Adenosine signaling via A2AR plays a key role in SD-induced PD exacerbation.
- Improving sleep quality and targeting gut microbiota or adenosine pathways may offer therapeutic strategies for PD.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

